Logo image of ACWN.DE

AS CREATION TAPETEN AG (ACWN.DE) Stock Fundamental Analysis

FRA:ACWN - Deutsche Boerse Ag - DE000A1TNNN5 - Common Stock - Currency: EUR

7.15  +0.1 (+1.42%)

Fundamental Rating

3

Overall ACWN gets a fundamental rating of 3 out of 10. We evaluated ACWN against 33 industry peers in the Household Durables industry. While ACWN seems to be doing ok healthwise, there are quite some concerns on its profitability. ACWN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACWN had negative earnings in the past year.
ACWN had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACWN reported negative net income in multiple years.
In the past 5 years ACWN always reported a positive cash flow from operatings.
ACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFACWN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

ACWN has a worse Return On Assets (-4.78%) than 87.88% of its industry peers.
ACWN has a Return On Equity of -7.55%. This is amonst the worse of the industry: ACWN underperforms 84.85% of its industry peers.
Industry RankSector Rank
ROA -4.78%
ROE -7.55%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)-1.51%
ROE(3y)-6.04%
ROE(5y)-2.3%
ROIC(3y)N/A
ROIC(5y)N/A
ACWN.DE Yearly ROA, ROE, ROICACWN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

ACWN has a better Gross Margin (51.00%) than 69.70% of its industry peers.
In the last couple of years the Gross Margin of ACWN has remained more or less at the same level.
ACWN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.05%
ACWN.DE Yearly Profit, Operating, Gross MarginsACWN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

ACWN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACWN has about the same amount of shares outstanding.
The number of shares outstanding for ACWN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ACWN has an improved debt to assets ratio.
ACWN.DE Yearly Shares OutstandingACWN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ACWN.DE Yearly Total Debt VS Total AssetsACWN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 2.27 indicates that ACWN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ACWN (2.27) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.09 indicates that ACWN is not too dependend on debt financing.
ACWN's Debt to Equity ratio of 0.09 is amongst the best of the industry. ACWN outperforms 84.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACC5.55%
ACWN.DE Yearly LT Debt VS Equity VS FCFACWN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

ACWN has a Current Ratio of 3.26. This indicates that ACWN is financially healthy and has no problem in meeting its short term obligations.
ACWN has a better Current ratio (3.26) than 84.85% of its industry peers.
ACWN has a Quick Ratio of 1.87. This is a normal value and indicates that ACWN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ACWN (1.87) is better than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.26
Quick Ratio 1.87
ACWN.DE Yearly Current Assets VS Current LiabilitesACWN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

ACWN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -203.29%.
Looking at the last year, ACWN shows a decrease in Revenue. The Revenue has decreased by -6.68% in the last year.
The Revenue has been decreasing by -4.62% on average over the past years.
EPS 1Y (TTM)-203.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1600%
Revenue 1Y (TTM)-6.68%
Revenue growth 3Y-8.56%
Revenue growth 5Y-4.62%
Sales Q2Q%-4.43%

3.2 Future

ACWN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.10% yearly.
The Revenue is expected to grow by 3.26% on average over the next years.
EPS Next Y114.96%
EPS Next 2Y55.66%
EPS Next 3Y35.1%
EPS Next 5YN/A
Revenue Next Year2.92%
Revenue Next 2Y3.46%
Revenue Next 3Y3.47%
Revenue Next 5Y3.26%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACWN.DE Yearly Revenue VS EstimatesACWN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ACWN.DE Yearly EPS VS EstimatesACWN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACWN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 7.08, which indicates a rather cheap valuation of ACWN.
Based on the Price/Forward Earnings ratio, ACWN is valued a bit cheaper than 78.79% of the companies in the same industry.
ACWN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 7.08
ACWN.DE Price Earnings VS Forward Price EarningsACWN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

ACWN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ACWN is more expensive than 75.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.79
ACWN.DE Per share dataACWN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

ACWN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ACWN's earnings are expected to grow with 35.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.66%
EPS Next 3Y35.1%

More info and screens

0

5. Dividend

5.1 Amount

ACWN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AS CREATION TAPETEN AG

FRA:ACWN (5/28/2025, 7:00:00 PM)

7.15

+0.1 (+1.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-07 2025-08-07
Inst Owners10.78%
Inst Owner ChangeN/A
Ins Owners59.38%
Ins Owner ChangeN/A
Market Cap19.73M
Analysts85.71
Price Target14.28 (99.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.08
P/S 0.18
P/FCF N/A
P/OCF 7.1
P/B 0.29
P/tB 0.32
EV/EBITDA 15.79
EPS(TTM)-1.86
EYN/A
EPS(NY)1.01
Fwd EY14.12%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)1.01
OCFY14.09%
SpS39.81
BVpS24.64
TBVpS22.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.78%
ROE -7.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)-1.51%
ROE(3y)-6.04%
ROE(5y)-2.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.05%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA 5.21
Cap/Depr 41.08%
Cap/Sales 2.63%
Interest Coverage N/A
Cash Conversion 243.76%
Profit Quality N/A
Current Ratio 3.26
Quick Ratio 1.87
Altman-Z 2.27
F-Score6
WACC5.55%
ROIC/WACCN/A
Cap/Depr(3y)47.95%
Cap/Depr(5y)59.64%
Cap/Sales(3y)2.26%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-203.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1600%
EPS Next Y114.96%
EPS Next 2Y55.66%
EPS Next 3Y35.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.68%
Revenue growth 3Y-8.56%
Revenue growth 5Y-4.62%
Sales Q2Q%-4.43%
Revenue Next Year2.92%
Revenue Next 2Y3.46%
Revenue Next 3Y3.47%
Revenue Next 5Y3.26%
EBIT growth 1Y-140.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year180.95%
EBIT Next 3Y47.21%
EBIT Next 5YN/A
FCF growth 1Y91.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.56%
OCF growth 3Y-57.28%
OCF growth 5YN/A